NCT06718270
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
- Locations
-
- Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Leukemia, Plasma Cell
Explore clinical trials studying Leukemia, Plasma Cell. Study availability and eligibility vary by location and protocol.
48 public trials
23 recruiting studies
Leukemia, Plasma Cell trial results
NCT06045091
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China
NCT05283993
- Conditions
- Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +44 more
- Locations
-
- Peking University First Hospital Beijing, China
Not Yet Recruiting
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
NCT07605416
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified
Not Yet Recruiting
CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia
NCT07652905
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
NCT07185490
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
Not specified
Not Yet Recruiting
Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia
NCT06830733
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Hospital Marqués de Valdecilla Santander, Cantabria, Spain
- Clínica Universitaria de Navarra Madrid, Spain
- Hospital 12 de Octubre Madrid, Spain
- Hospital Universitario Virgen de la Arrixaca Murcia, Spain
Not Yet Recruiting
An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT06655519
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
Not specified
Not Yet Recruiting
Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation
NCT05054478
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified
NCT02722668
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, +74 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States